Germany Reports More AstraZenecaza Blood Clot Cases, 7 Dead

Germany’s medical regulator, the Paul Ehrlich Institute reported 21 cases of rare blood clots in people who had been administered AstraZeneca’s coronavirus vaccine.

The blood clot was identified to be mostly sinus vein thrombosis cases wherein a clot form in the brain’s venous sinuses which prevents blood from draining out of the brain.

Among the cases reported, 7 have died as a result of the blood clot while 12 had an abnormally low level of platelets.

A majority of those who contracted blood clots were women n women ages 20 to 63, while two were male aged 36 and 57.

Since the blood clot cases were reported earlier this month EMA, the European Union’s medical regulator suggested that warnings about possible rare side effects should be mandatory for vaccines.

Around 2.27 million doses of the AstraZeneca vaccine have been administered in Germany so far.

© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.